Skip to main content
Joseph Stavas, MD, Radiology, Raleigh, NC

JosephStavasMDMPH, FACR, FSIR

Radiology Raleigh, NC

Pediatric Radiology, Vascular & Interventional Radiology

Senior VP Global Clinical Development

Dr. Stavas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Stavas' full profile

Already have an account?

Education & Training

  • University North Carolina
    University North CarolinaMPH, Health Policy/Management, Honors, 2009 - 2011
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Radiology-Diagnostic, 1986 - 1987
  • University of Minnesota
    University of MinnesotaResidency, Radiology-Diagnostic, 1982 - 1986
  • Creighton University School of Medicine
    Creighton University School of MedicineClass of 1982

Certifications & Licensure

  • American Board of Radiology Pediatric Radiology
  • American Board of Radiology Interventional Radiology and Diagnostic Radiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Massive Inferior Vena Cava Thrombosis Associated with Retroperitoneal Venolymphatic Malformation  
    Raviteja R Guddeti, Himanshu Agarwal, Joseph Stavas, ScienceDirect

Press Mentions

  • ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease
    ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney DiseaseJanuary 10th, 2023
  • ProKidney to Present REACT® at 4th Annual CKD Summit
    ProKidney to Present REACT® at 4th Annual CKD SummitMarch 1st, 2022
  • ProKidney Announces Online Publication of Trial Design for Phase II Multicenter Clinical Trial of REACT® Autologous Cell Therapy for Treatment of Chronic Kidney Disease
    ProKidney Announces Online Publication of Trial Design for Phase II Multicenter Clinical Trial of REACT® Autologous Cell Therapy for Treatment of Chronic Kidney DiseaseJanuary 27th, 2022
  • Join now to see all

Industry Relationships

  • SVP Clinical Development, ProKidney